1Sredni B,Tichler T,Shani A,et al.Predominance of TH1 response in tumor-bearing mice and cancer patients treated with AS101[].Journal of the National Cancer Institute.1996
2Huang S,Xie K,Bucana CD,et al.Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis[].Clinical Cancer Research.1996
3Chen YM,Yang WK,Whang Peng J,et al.Elevation of interleukin-10 levels in malignant pleural effusion[].Chest.1996
4Ito N,Nakamura H,Tanaka Y,et al.Lung carcinoma: analysis of helper type 1 and 2 cells and T cytotoxic type 1 and 2 cells by intracellular cytokine detection with flow cytometry[].Cancer.1999
5Asselin Paturel C,Echchakir H,Carayol G,et al.Quantitative analysis of Th1, Th2 and TGF-β1 cytokine expression in tumor, TIL and PBL of nonsmall cell lung cancer patients[].International Journal of Cancer.1998
6De Vita F,Orditura M,Galizia G,et al.Serum Interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients[].Chest.2000
7Stolina M,Sharma S,Lin Y,et al.Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis[].J Immunol.2000
8Chen YM,Yang WK,Ting CC,et al.Cross regulation by IL-10 and IL2 /IL-12 of the helper T cell and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients[].Chest.1997
9Fujimoto T,Duda RB,Szilvasi A,et al.Streptococcal preparation OK432 is a potent inducer of IL-12 and a T helper cell 1 dominant state[].J Immunol.1997
10Yanagawa H,Takeuchi E,Suzuki Y,et al.Presence and potent immunosuppressive role of interleukin-10 in malignant pleural effusion due to lung cancer[].Cancer Letters.1999
